Jennifer Sutton

Jennifer Sutton currently serves as the Senior Director, Head of GxP Quality Audit Management at Immunovant, a position held since July 2024. Prior roles include Director, Associate Director and Senior Manager of GxP Compliance Audit at Biomarin from May 2017 to May 2024, and Global Operations Auditor at Mylan Pharmaceuticals Inc. from May 2012 to May 2017. Additionally, Jennifer worked as a Regulatory Compliance Specialist at Aspen Pharma from 2011 to 2012 and as a Compliance Officer at Astellas Pharma Ireland Ltd. from 2010 to 2011. Jennifer began her career as a Quality Assurance Specialist at Wyeth Biotech in 2004 and went on to fulfil other Quality Assurance roles with Shionogi Pharma and Allergen Pharmaceuticals. Jennifer earned a Bachelor of Science Degree in Pharmaceutical Technology from the Technical University of Dublin between 2002 and 2006 and also earned a Master of Science Degree in Pharmaceutical Science from the Royal College of Surgeons between 2014 and 2016.